Company Filing History:
Years Active: 2014-2018
Title: The Innovations of Suzette Belder-Carr
Introduction
Suzette Belder-Carr is a notable inventor based in Hopewell, NJ (US). She has made significant contributions to the field of autoimmune disease treatment, holding a total of 4 patents. Her work focuses on innovative methods that aim to improve the lives of individuals suffering from various autoimmune conditions.
Latest Patents
Among her latest patents are two groundbreaking inventions. The first is titled "Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule." This invention relates to compositions and methods for treating autoimmune diseases by administering a CTLA4 molecule that blocks endogenous B7 molecules from binding their ligands. The second patent is "Methods for treating scleroderma by administering a soluble CTLA4 molecule." Similar to her first patent, this invention also focuses on treating autoimmune diseases, specifically scleroderma, through the administration of a CTLA4 molecule.
Career Highlights
Suzette is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and innovations. Her work has been instrumental in developing new therapeutic approaches for autoimmune diseases, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Suzette has collaborated with esteemed colleagues, including Robert Cohen and David Hagerty. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Suzette Belder-Carr's contributions to the field of autoimmune disease treatment through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic options, making a significant impact in the medical community.